Search Results for ""
- U.S. Navy Biomedical and Human Systems Communities of Interest (COI)
The Department of Defense (DoD) and other military assisting Federal Agencies have a large and diverse community of subject matter experts (SME) who are eager to collaborate with industry and universities. These extraordinary SMEs are driven to accelerate new and novel dual-use technologies forward ... - Biomedical and Line DoD Technology Readiness Levels (TRLs)
Technology readiness assessments (TRA) are widely utilized by the U.S. Department of Defense (DoD) to determine a technology’s readiness for use in acquisition programs and projects (see the U.S. Government Accountability Office’s Technology Readiness Assessment Guide). The TRA frequentl... - Agency TRLs
Some Federal agencies have defined their own set of TRLs to better meet their specific mission requirements. Agency-specific TRLs have been defined for the Biomedical Advanced Research & Development Authority (BARDA), Department of Defense (DoD), Department of Energy (DoE), National Aeronaut... - Medical Countermeasure (MCM) TRLs
Medical countermeasures (MCMs) are developed to prepare and protect against both natural and man-made public health threats. TRLs are defined for MCM products, such as a drug or vaccine, and for Product Development Tools (PDTs), such as assays, models, and reagents. TRL 1 Review of... - Biomedical TRLs
Medical related products require TRL definitions and descriptions that are appropriate to the technologies upon which they are based and that account for the statues and regulations that govern their development and use. Biomedical TRLs are further categorized into TRLs for drugs, vaccines, devi... - Technology Readiness Levels (TRLs)
The maturity of a technology under development is frequently evaluated using a Technology Readiness Level (TRL) scale. TRLs are ordered according to the characteristics of the demonstration or testing environment under which a given technology was tested at defined points in time. The scale co... - Military Health System (MHS) to Defense Health Agency (DHA) – 2018 R&D Changes
In 2018, the Defense Health Agency (DHA) will begin making major reforms to the Military Health System (MHS) and changes to the organizational structure of several Department of Defense (DoD) medical research programs. We’re following these R&D transitions and summarized below are a few of... - Traumatic Brain Injury (TBI) R&D Funding from the Congressionally Directed Medical Research Programs (CDMRP)
Traumatic Brain Injury (TBI) is a significant health issue that occurs at a high rate in military populations. According to the Defense and Veterans Brain Injury Center, more than 380,000 Service members have been diagnosed with TBI since 2000. TBI is also a significant public health burden that mos... - Cancer R&D Funding from the Congressionally Directed Medical Research Program (CDMRP)
Does your company have a therapeutic candidate (small molecule, monoclonal antibody, combination product, or other) for the treatment of a type of cancer? Does your therapeutic candidate have multiple indications for multiple types of cancers (e.g., drugs targeting reactive oxygen species [ROS] or c... - ORTHOPAEDIC TRAUMA
Orthopaedic Trauma U.S. military personnel are particularly vulnerable to orthopaedic injuries sustained during combat-related activities. These injuries tend to be very complex, involving multiple tissues such as skin, bone, muscle, cartilage, and nerves. Further, our warfighters often susta...